Publication date: 9 January 2027 Source: Neuroscience, Volume 620 Author(s): Mustafa T Ardah, Aziz Kubaev, Malathi Hanumanthayya, Maryam Abdul Al-Hussein, Ahmed Faisal Mutee, Mukhammadali Buriev, Nasiba Jumaniyazova, Shefali
Quinolinic acid as a central immunometabolic mediator of inflammation, neurodegeneration, and disease pathogenesis. // Regulatory Toxicology and Pharmacology. – URL: https://www.sciencedirect.com/science/article/pii/S0306452226007347?dgcid=rss_sd_all
Quinolinic acid as a central immunometabolic mediator of inflammation, neurodegeneration, and disease pathogenesis. Regulatory Toxicology and Pharmacology. https://www.sciencedirect.com/science/article/pii/S0306452226007347?dgcid=rss_sd_all
“Quinolinic acid as a central immunometabolic mediator of inflammation, neurodegeneration, and disease pathogenesis.” Regulatory Toxicology and Pharmacology.
@article{article14014,
title = {Quinolinic acid as a central immunometabolic mediator of inflammation, neurodegeneration, and disease pathogenesis},
journal = {Regulatory Toxicology and Pharmacology},
url = {https://www.sciencedirect.com/science/article/pii/S0306452226007347?dgcid=rss_sd_all}
}
Publication date: November 2026 Source: Neurophysiologie Clinique, Volume 56, Issue 6 Author(s): Benjamin Yamin Ali Khan, Gaia Fanella, Thomas Harbo, Jane Agergaard, Berit Schiøttz-Christensen, Eva Kildal Hejbøl, Henrik Daa Schrøder,...